Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Somatic Embryonic FGFR2 Mutations in Keratinocytic Epidermal Nevi.

Toll A, Fernández LC, Pons T, Groesser L, Sagrera A, Carrillo-de Santa Pau E, Vicente A, Baselga E, Vázquez M, Beltrán S, Pisano DG, Rueda D, Gut M, Pujol RM, Hafner C, Gut I, Valencia A, Real FX.

J Invest Dermatol. 2016 Aug;136(8):1718-1721. doi: 10.1016/j.jid.2016.03.040. Epub 2016 Apr 19. No abstract available.

2.

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

Balbás-Martínez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Márquez M, Vazquez M, Lapi E, Castro-Giner F, Beltran S, Bayés M, Carrato A, Cigudosa JC, Domínguez O, Gut M, Herranz J, Juanpere N, Kogevinas M, Langa X, López-Knowles E, Lorente JA, Lloreta J, Pisano DG, Richart L, Rico D, Salgado RN, Tardón A, Chanock S, Heath S, Valencia A, Losada A, Gut I, Malats N, Real FX.

Nat Genet. 2013 Dec;45(12):1464-9. doi: 10.1038/ng.2799. Epub 2013 Oct 13.

3.

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.

Allory Y, Beukers W, Sagrera A, Flández M, Marqués M, Márquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, Carrato A, Lloreta J, Lorente JA, Carrillo-de Santa Pau E, Masius RG, Kogevinas M, Steyerberg EW, van Tilborg AA, Abas C, Orntoft TF, Zuiverloon TC, Malats N, Zwarthoff EC, Real FX.

Eur Urol. 2014 Feb;65(2):360-6. doi: 10.1016/j.eururo.2013.08.052. Epub 2013 Sep 7.

PMID:
24018021
4.

Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.

Groesser L, Herschberger E, Sagrera A, Shwayder T, Flux K, Ehmann L, Wollenberg A, Torrelo A, Bagazgoitia L, Diaz-Ley B, Tinschert S, Oschlies I, Singer S, Mickler M, Toll A, Landthaler M, Real FX, Hafner C.

J Invest Dermatol. 2013 Aug;133(8):1998-2003. doi: 10.1038/jid.2013.24. Epub 2013 Jan 21.

5.

Cancer development induced by graded expression of Snail in mice.

Pérez-Mancera PA, Pérez-Caro M, González-Herrero I, Flores T, Orfao A, de Herreros AG, Gutiérrez-Adán A, Pintado B, Sagrera A, Sánchez-Martín M, Sánchez-García I.

Hum Mol Genet. 2005 Nov 15;14(22):3449-61. Epub 2005 Oct 5.

PMID:
16207734
6.

SLUG (SNAI2) deletions in patients with Waardenburg disease.

Sánchez-Martín M, Rodríguez-García A, Pérez-Losada J, Sagrera A, Read AP, Sánchez-García I.

Hum Mol Genet. 2002 Dec 1;11(25):3231-6.

PMID:
12444107
7.

Fusogenic activity of reconstituted newcastle disease virus envelopes: a role for the hemagglutinin-neuraminidase protein in the fusion process.

Cobaleda C, Muñoz-Barroso I, Sagrera A, Villar E.

Int J Biochem Cell Biol. 2002 Apr;34(4):403-13.

PMID:
11854039
8.
9.

Recombinant Newcastle disease virus as a vaccine vector.

Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A, Villar E, García-Sastre A, Palese P.

J Virol. 2001 Dec;75(23):11868-73.

10.

Study of the influence of salt concentration on Newcastle disease virus matrix protein aggregation.

Sagrera A, Cobaleda C, Berger S, Marcos MJ, Shnyrov V, Villar E.

Biochem Mol Biol Int. 1998 Oct;46(3):429-35.

PMID:
9818082
11.

A differential scanning calorimetric study of Newcastle disease virus: identification of proteins involved in thermal transitions.

Shnyrov VL, Zhadan GG, Cobaleda C, Sagrera A, Muñoz-Barroso I, Villar E.

Arch Biochem Biophys. 1997 May 1;341(1):89-97.

PMID:
9143357
12.

Supplemental Content

Loading ...
Support Center